Natixis Investment Managers International Moderna, Inc. Transaction History

Natixis Investment Managers International

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $196,661 - $296,494	-1,679 Reduced 18.31%	7,491 $1.07 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $1.16 Million - $2.16 Million	9,170 New	9,170 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $15.2 Million - $24.8 Million	-67,210 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $46.4 Million - $101 Million	-209,110 Reduced 75.68%	67,210 $25.9 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $35.9 Million - $64.9 Million	276,320 New	276,320 $64.9 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.